Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hospital Administration | 2 | 2020 | 650 | 1.02 | Why? |
| Yttrium Radioisotopes | 1 | 2018 | 12 | 0.74 | Why? |
| Phenylurea Compounds | 1 | 2018 | 101 | 0.67 | Why? |
| Niacinamide | 1 | 2018 | 135 | 0.64 | Why? |
| Liver Transplantation | 10 | 2021 | 2864 | 0.58 | Why? |
| Carcinoma, Hepatocellular | 5 | 2018 | 1222 | 0.56 | Why? |
| Liver Neoplasms | 5 | 2018 | 1666 | 0.49 | Why? |
| Liver Cirrhosis | 9 | 2020 | 1810 | 0.42 | Why? |
| Emergency Medicine | 1 | 2020 | 936 | 0.41 | Why? |
| Hepatitis C, Chronic | 4 | 2019 | 973 | 0.36 | Why? |
| Hepatitis C | 4 | 2017 | 1514 | 0.30 | Why? |
| Sofosbuvir | 2 | 2017 | 518 | 0.24 | Why? |
| End Stage Liver Disease | 2 | 2017 | 418 | 0.24 | Why? |
| Complement Pathway, Mannose-Binding Lectin | 1 | 2020 | 44 | 0.21 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.20 | Why? |
| Serum Amyloid P-Component | 1 | 2021 | 193 | 0.19 | Why? |
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2018 | 16 | 0.18 | Why? |
| Italy | 15 | 2021 | 38444 | 0.18 | Why? |
| Ascites | 1 | 2018 | 65 | 0.18 | Why? |
| Guanine | 1 | 2019 | 146 | 0.18 | Why? |
| Hepatic Encephalopathy | 1 | 2018 | 88 | 0.17 | Why? |
| Lymphoma, Follicular | 1 | 2018 | 109 | 0.17 | Why? |
| Waiting Lists | 4 | 2021 | 1388 | 0.17 | Why? |
| Quinazolinones | 1 | 2018 | 135 | 0.17 | Why? |
| Quinolones | 1 | 2019 | 167 | 0.17 | Why? |
| Chemoembolization, Therapeutic | 1 | 2018 | 144 | 0.16 | Why? |
| Antiviral Agents | 10 | 2020 | 41703 | 0.16 | Why? |
| Peritonitis | 1 | 2019 | 217 | 0.16 | Why? |
| Thrombotic Microangiopathies | 1 | 2020 | 335 | 0.16 | Why? |
| Ribavirin | 3 | 2017 | 1182 | 0.16 | Why? |
| Cholangitis, Sclerosing | 1 | 2017 | 106 | 0.15 | Why? |
| Albumins | 1 | 2018 | 324 | 0.15 | Why? |
| Drug Substitution | 1 | 2019 | 385 | 0.15 | Why? |
| Imidazoles | 2 | 2017 | 631 | 0.15 | Why? |
| Interleukin-8 | 1 | 2021 | 964 | 0.14 | Why? |
| Tenofovir | 1 | 2019 | 449 | 0.14 | Why? |
| Transplant Recipients | 3 | 2021 | 4982 | 0.14 | Why? |
| Fibrosis | 1 | 2018 | 800 | 0.13 | Why? |
| Bacterial Infections | 2 | 2019 | 2229 | 0.13 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.13 | Why? |
| Liver Function Tests | 1 | 2020 | 1325 | 0.13 | Why? |
| Hepacivirus | 3 | 2017 | 1509 | 0.13 | Why? |
| Hepatitis, Autoimmune | 1 | 2017 | 254 | 0.13 | Why? |
| Hygiene | 1 | 2020 | 987 | 0.13 | Why? |
| Purines | 1 | 2018 | 816 | 0.12 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.12 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.12 | Why? |
| Hepatitis B, Chronic | 1 | 2019 | 616 | 0.11 | Why? |
| Postoperative Care | 1 | 2017 | 755 | 0.11 | Why? |
| Antibodies, Monoclonal | 2 | 2021 | 8041 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 877 | 0.10 | Why? |
| Hepatitis B | 1 | 2018 | 888 | 0.10 | Why? |
| Drug Therapy, Combination | 6 | 2018 | 7268 | 0.10 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.09 | Why? |
| Endothelium, Vascular | 1 | 2020 | 1751 | 0.09 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.09 | Why? |
| Ventilators, Mechanical | 1 | 2021 | 2193 | 0.09 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.09 | Why? |
| Antimicrobial Stewardship | 1 | 2017 | 931 | 0.09 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| C-Reactive Protein | 2 | 2021 | 7972 | 0.09 | Why? |
| Kidney Diseases | 1 | 2019 | 1434 | 0.08 | Why? |
| Preoperative Care | 1 | 2017 | 1515 | 0.08 | Why? |
| Sustained Virologic Response | 2 | 2019 | 378 | 0.08 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2021 | 243684 | 0.08 | Why? |
| Valine | 2 | 2017 | 359 | 0.07 | Why? |
| Kaplan-Meier Estimate | 3 | 2021 | 4260 | 0.07 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.07 | Why? |
| Immunosuppressive Agents | 3 | 2020 | 6331 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Aged | 13 | 2021 | 215776 | 0.07 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.07 | Why? |
| Kidney | 1 | 2019 | 3648 | 0.07 | Why? |
| Carbamates | 2 | 2017 | 485 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2017 | 1996 | 0.06 | Why? |
| Male | 17 | 2021 | 367725 | 0.06 | Why? |
| Pyrrolidines | 2 | 2017 | 558 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| Humans | 29 | 2021 | 930598 | 0.06 | Why? |
| Recurrence | 3 | 2017 | 3675 | 0.06 | Why? |
| Female | 16 | 2021 | 380317 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.06 | Why? |
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2020 | 41 | 0.05 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.05 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Drug Interactions | 2 | 2018 | 1653 | 0.05 | Why? |
| Survival Rate | 3 | 2021 | 9206 | 0.05 | Why? |
| Drug Administration Schedule | 2 | 2017 | 2324 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.05 | Why? |
| Aldehyde Oxidase | 1 | 2018 | 10 | 0.05 | Why? |
| Paracentesis | 1 | 2018 | 25 | 0.05 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.05 | Why? |
| Cytochrome P-450 CYP3A | 1 | 2018 | 88 | 0.05 | Why? |
| Hepatitis B Core Antigens | 1 | 2018 | 76 | 0.04 | Why? |
| Tissue Donors | 2 | 2018 | 1679 | 0.04 | Why? |
| Furosemide | 1 | 2018 | 99 | 0.04 | Why? |
| Simeprevir | 1 | 2017 | 62 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Hyperkalemia | 1 | 2018 | 140 | 0.04 | Why? |
| Mineralocorticoid Receptor Antagonists | 1 | 2018 | 203 | 0.04 | Why? |
| Graft Rejection | 2 | 2017 | 1766 | 0.04 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.04 | Why? |
| Diuretics | 1 | 2018 | 326 | 0.04 | Why? |
| Cholestasis | 1 | 2017 | 114 | 0.04 | Why? |
| Colitis | 1 | 2018 | 266 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2018 | 511 | 0.04 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.03 | Why? |
| Tacrolimus | 1 | 2017 | 435 | 0.03 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2021 | 830 | 0.03 | Why? |
| Hyponatremia | 1 | 2018 | 371 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Chemoprevention | 1 | 2018 | 585 | 0.03 | Why? |
| Cyclosporine | 1 | 2017 | 449 | 0.03 | Why? |
| Compassionate Use Trials | 1 | 2017 | 632 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Delphi Technique | 1 | 2017 | 1257 | 0.03 | Why? |
| Continuous Positive Airway Pressure | 1 | 2021 | 1187 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Adult | 7 | 2021 | 244371 | 0.02 | Why? |
| Interferon-alpha | 1 | 2017 | 1442 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Recovery of Function | 1 | 2019 | 2461 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.02 | Why? |
| Health Care Surveys | 1 | 2018 | 2942 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Smoking | 1 | 2021 | 3358 | 0.02 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.02 | Why? |
| Critical Pathways | 1 | 2017 | 1587 | 0.02 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.02 | Why? |
| Coinfection | 2 | 2017 | 6820 | 0.02 | Why? |
| Health Status | 1 | 2020 | 3259 | 0.02 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.02 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.02 | Why? |
| Mobile Applications | 1 | 2021 | 3032 | 0.02 | Why? |
| Myocardial Infarction | 1 | 2021 | 3361 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.01 | Why? |
| HIV Infections | 2 | 2017 | 11620 | 0.01 | Why? |
| Registries | 1 | 2021 | 12327 | 0.01 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2019 | 10697 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Fagiuoli's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(219)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_